Omeros corporation receives $200 million milestone payment from rayner surgical

Seattle--( business wire )--omeros corporation (nasdaq: omer) today announced that rayner surgical, inc. (“rayner”) has paid the $200 million milestone payment due to omeros under the asset purchase agreement, dated december 1, 2021 (the “agreement”), pursuant to which omeros sold its ophthalmology product omidria® to rayner in december of 2021.
OMER Ratings Summary
OMER Quant Ranking